Triptolide sensitizes AML cells to TRAIL-induced apoptosis via decrease of XIAP and p53-mediated increase of DR5

Blood
Bing Z CarterMichael Andreeff

Abstract

Acute myeloid leukemia (AML) cells are relatively resistant to tumor necrosis factor alpha-related apoptosis-inducing ligand (TRAIL). We previously reported that triptolide, a potent anticancer agent from a Chinese herb, decreases XIAP in leukemic cells. We evaluated the combination of triptolide and TRAIL and found synergistic promotion of apoptosis in AML cells. XIAP-overexpressing U937 cells (U937XIAP) were more resistant to TRAIL than U937neo cells, and inhibition of XIAP with the small-molecule inhibitor 1396-11 enhanced TRAIL-induced apoptosis, implying XIAP as a resistance factor in AML. Furthermore, triptolide increased DR5 levels in OCI-AML3, while the DR5 increase was blunted in p53-knockdown OCI-AML3 and p53-mutated U937 cells, confirming a role for p53 in the regulation of DR5. In support of this finding, disruption of MDM2-p53 binding with subsequent increase in p53 levels by nutlin3a increased DR5 levels and sensitized OCI-AML3 cells to TRAIL. The combination of 1396-11 plus nutlin3a plus TRAIL was more effective than either the 1396-11 and TRAIL or nutlin3a and TRAIL combinations in OCI-AML3 cells, further supporting the role of triptolide as a sensitizer to TRAIL-induced apoptosis in part by independent modulati...Continue Reading

References

Jul 1, 1993·Genes & Development·X WuA J Levine
Sep 1, 1996·European Journal of Haematology·B SeligerA Neubauer
Apr 1, 1997·Seminars in Arthritis and Rheumatism·P E Lipsky, X L Tao
Nov 5, 1997·Nature Genetics·G S WuW S el-Deiry
Nov 24, 1998·Immunopharmacology·Y YangL Li
May 1, 1999·The Journal of Biological Chemistry·K Y LeeG D Rosen
Jul 20, 1999·The Journal of Clinical Investigation·A AshkenaziR H Schwall
Aug 10, 2000·The Journal of Biological Chemistry·R DattaD Kufe
Oct 29, 2000·The Journal of Biological Chemistry·W T ChangG D Rosen
Apr 12, 2002·Oncogene·Simone FuldaKlaus-Michael Debatin
Feb 4, 2003·Nature Reviews. Cancer·Patrick Chène
Mar 26, 2003·Cell Death and Differentiation·Lars E French, Jürg Tschopp
Jul 16, 2003·Laboratory Investigation; a Journal of Technical Methods and Pathology·Hiroshi OkanoTakeshi Nakano
Jan 6, 2004·Science·Lyubomir T VassilevEmily A Liu
Jul 15, 2004·Current Opinion in Pharmacology·Sean K Kelley, Avi Ashkenazi
Oct 27, 2004·Cancer Science·Hideo YagitaKo Okumura
Nov 20, 2004·Cancer Gene Therapy·Lidong Zhang, Bingliang Fang
May 5, 2005·Blood·Martin S TallmanJacob M Rowe

❮ Previous
Next ❯

Citations

Dec 31, 2010·Frontiers of Medicine in China·Li WangPing Zou
Oct 30, 2008·Journal of Medicinal Chemistry·Jui-Wen HuangMaurizio Pellecchia
Dec 15, 2010·Nature Reviews. Drug Discovery·Lynn BedfordJames E Brownell
Aug 13, 2011·Clinical and Experimental Pharmacology & Physiology·Kwong-Fai WongJohn M Luk
Jul 23, 2011·Chinese Medicine·Wen TanYitao Wang
Mar 28, 2013·Journal of Hematology & Oncology·Manujendra N SahaHong Chang
Jun 17, 2010·Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine·Wen-Jie MaoMing-Chang Zhang
Aug 19, 2014·Trends in Pharmacological Sciences·Sahdeo PrasadBharat B Aggarwal
May 10, 2011·Expert Opinion on Therapeutic Targets·Giorgio ZauliPaola Secchiero
Oct 2, 2015·The FEBS Journal·Erik L BrincksThomas S Griffith
Apr 16, 2013·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Cheng-Yun JinYung Hyun Choi
Jan 25, 2011·International Immunopharmacology·Qiuyan Liu
Aug 10, 2010·Leukemia Research·Gui-Sheng ZhouGuang-Biao Zhou
Aug 10, 2010·The Journal of Surgical Research·Kimberly A ClawsonSelwyn M Vickers
Mar 2, 2012·The Journal of Investigative Dermatology·Valentina ManféRobert Gniadecki
Oct 17, 2008·Experimental Hematology·Arnaud PigneuxFrancis Belloc
Nov 13, 2010·Journal of Cellular and Molecular Medicine·Eva SzegezdiAfshin Samali

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.